Merck Profit Rises on Cost-Cutting

Merck said its first-quarter earnings rose 7% as the drugmaker benefited from cost-cutting efforts and the divestitures of some assets, offsetting a modest revenue decline.

Leave a Reply

Your email address will not be published. Required fields are marked *